Prognostic value of estimating appendicular muscle mass in heart failure using creatinine/cystatin C

29 August 2022 (11:15 - 12:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Tutomu Sunayama

Juntendo University School of Medicine, Tokyo (Japan)

7 More presentations in this session

Presentation thumbnail

Predicting the long-termoutcome of patients admitted with acute heart failure to the emergency department using renal markers

Doctor J. Borges-Rosa (Coimbra, PT)

Abstract Slides

Presentation thumbnail

Clinical impact of chronic kidney disease on appendicular skeletal muscle mass and mortality in hospitalized patients with acute heart failure

Mr E. Akiyama (Saitama, JP)

Abstract Slides

Presentation thumbnail

Causes of death in patients with chronic kidney disease: Insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials

Professor A. Singh (Boston, US)

Abstract Slides

Presentation thumbnail

Implications of the 2021 CKD-EPI cystatin C/creatinine eGFR equation for eligibility for therapy in HFrEF: Insights from PARADIGM-HF

Doctor P. Tolomeo (Glasgow, GB)

Abstract Slides

Presentation thumbnail

Incidence of heart failure and renal endpoints in heart failure patients with and without severe chronic kidney disease: a nationwide real-life study of 21,959 patients

Miss D. Zahir (Copenhagen, DK)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure - The kidney and heart failure

The Event

Event poster

ESC Congress 2022

29 August 2022 11:15 CET

You may be interested in

Congress Session

From genetic signatures to clinical implications

Congress Presentation

A proteo-genomic discovery approach to identify markers of early heart failure

Congress Presentation

State-of-the-art lecture on current state of the diagnosis of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources